Healthcare >> CEO Interviews >> August 14, 2000
W. SCOTT HARKONEN, MD founded InterMune Pharmaceuticals, Inc. in
February 1998 and has been Chief Executive Officer and President since
the inception. Dr. Harkonen has served as a member of the Board of
Directors since inception and is currently the Chairman of the Board.
From September 1995 to April 1999, Dr. Harkonen served as Senior Vice
President of Product Development and Operations for the Connetics
Corporation, where he was instrumental in the spin-out of InterMune from
Connetics. From 1991 to 1995, he was the Vice President of Medical and
Regulatory Affairs at Univax Biologics. Dr. Harkonen is well-known and
respected by the investment community, having played key roles in both
the Univax and the Connetics public financings, including their IPOs.
Dr. Harkonen received an MD from the University of Minnesota and holds
an MBA from the Haas School of Business at the University of California,
Berkeley. Profile
InterMune Pharmaceuticals?
Dr. Harkonen: InterMune develops and commercializes products for the
treatment pulmonary,
